Drug information for ORGARAN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
750 UNITS/0.6ML
Discontinued
DANAPAROID SODIUM
danaproid
ORGANON USA INC
20430
2010-01-05 Review
2001-07-13 Label
2001-07-13 Letter
2001-07-13 Review
Drug Adverse Effects information for ORGARAN
Role code
Indications
Reaction
# Reports
PS
DISSEMINATED INTRAVASCULAR COAGULATION
TRANSAMINASES INCREASED
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD PRESSURE DECREASED
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
BRONCHOSPASM
8
PS
PRODUCT USED FOR UNKNOWN INDICATION
COAGULOPATHY
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INEFFECTIVE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
8
PS
PRODUCT USED FOR UNKNOWN INDICATION
GENERALISED OEDEMA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
PLATELET COUNT DECREASED
1
C
ACUTE LYMPHOCYTIC LEUKAEMIA
DRUG INTERACTION
8
C
ACUTE LYMPHOCYTIC LEUKAEMIA
ILEUS PARALYTIC
8
C
ANTIBIOTIC PROPHYLAXIS
DRUG INTERACTION
2
C
ANTIBIOTIC PROPHYLAXIS
ILEUS PARALYTIC
2
C
BONE MARROW TRANSPLANT
ACUTE PULMONARY OEDEMA
8
C
BONE MARROW TRANSPLANT
ALANINE AMINOTRANSFERASE INCREASED
8
C
BONE MARROW TRANSPLANT
ASPARTATE AMINOTRANSFERASE INCREASED
8
C
BONE MARROW TRANSPLANT
BILIRUBIN CONJUGATED INCREASED
8
C
BONE MARROW TRANSPLANT
BLOOD ALKALINE PHOSPHATASE INCREASED
8
C
BONE MARROW TRANSPLANT
BLOOD BILIRUBIN INCREASED
8
C
BONE MARROW TRANSPLANT
BLOOD CREATININE INCREASED
8
C
BONE MARROW TRANSPLANT
CAPILLARY LEAK SYNDROME
8
C
BONE MARROW TRANSPLANT
GAMMA-GLUTAMYLTRANSFERASE INCREASED
8
C
BONE MARROW TRANSPLANT
GENERALISED OEDEMA
8
C
BONE MARROW TRANSPLANT
HEPATIC INFECTION
8
C
BONE MARROW TRANSPLANT
HUMAN HERPESVIRUS 6 INFECTION
8
C
BONE MARROW TRANSPLANT
VENOOCCLUSIVE LIVER DISEASE
8
C
BONE MARROW TRANSPLANT
WEIGHT INCREASED
8
C
HYPEREOSINOPHILIC SYNDROME
ACUTE PULMONARY OEDEMA
2
C
HYPEREOSINOPHILIC SYNDROME
ALANINE AMINOTRANSFERASE INCREASED
2
C
HYPEREOSINOPHILIC SYNDROME
ASPARTATE AMINOTRANSFERASE INCREASED
2
C
HYPEREOSINOPHILIC SYNDROME
BILIRUBIN CONJUGATED INCREASED
2
C
HYPEREOSINOPHILIC SYNDROME
BLOOD ALKALINE PHOSPHATASE INCREASED
2
C
HYPEREOSINOPHILIC SYNDROME
BLOOD BILIRUBIN INCREASED
2
C
HYPEREOSINOPHILIC SYNDROME
BLOOD CREATININE INCREASED
2
C
HYPEREOSINOPHILIC SYNDROME
CAPILLARY LEAK SYNDROME
2
C
HYPEREOSINOPHILIC SYNDROME
GAMMA-GLUTAMYLTRANSFERASE INCREASED
2
C
HYPEREOSINOPHILIC SYNDROME
GENERALISED OEDEMA
2
C
HYPEREOSINOPHILIC SYNDROME
HEPATIC INFECTION
2
C
HYPEREOSINOPHILIC SYNDROME
HUMAN HERPESVIRUS 6 INFECTION
2
C
HYPEREOSINOPHILIC SYNDROME
VENOOCCLUSIVE LIVER DISEASE
2
C
HYPEREOSINOPHILIC SYNDROME
WEIGHT INCREASED
2
C
HYPERTENSION
DRUG INTERACTION
4
C
HYPERTENSION
ILEUS PARALYTIC
4
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INTERACTION
4
C
PRODUCT USED FOR UNKNOWN INDICATION
ILEUS PARALYTIC
4
C
PROPHYLAXIS
DRUG INTERACTION
9
C
PROPHYLAXIS
ILEUS PARALYTIC
9
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
DRUG INTERACTION
2
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
ILEUS PARALYTIC
2
C
STAPHYLOCOCCAL MEDIASTINITIS
LACTIC ACIDOSIS
1
C
STAPHYLOCOCCAL MEDIASTINITIS
REFRACTORY ANAEMIA
1
C
STAPHYLOCOCCAL MEDIASTINITIS
RENAL FAILURE
1
C
STAPHYLOCOCCAL MEDIASTINITIS
THROMBOCYTOPENIA
1
C
THROMBOSIS
ACUTE PULMONARY OEDEMA
2
C
THROMBOSIS
ALANINE AMINOTRANSFERASE INCREASED
2
C
THROMBOSIS
ASPARTATE AMINOTRANSFERASE INCREASED
2
C
THROMBOSIS
BILIRUBIN CONJUGATED INCREASED
2
C
THROMBOSIS
BLOOD ALKALINE PHOSPHATASE INCREASED
2
C
THROMBOSIS
BLOOD BILIRUBIN INCREASED
2
C
THROMBOSIS
BLOOD CREATININE INCREASED
2
C
THROMBOSIS
CAPILLARY LEAK SYNDROME
2
C
THROMBOSIS
GAMMA-GLUTAMYLTRANSFERASE INCREASED
2
C
THROMBOSIS
GENERALISED OEDEMA
2
C
THROMBOSIS
HEPATIC INFECTION
2
C
THROMBOSIS
HUMAN HERPESVIRUS 6 INFECTION
2
C
THROMBOSIS
VENOOCCLUSIVE LIVER DISEASE
2
C
THROMBOSIS
WEIGHT INCREASED
2
Ads by Google